{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:51:33Z","timestamp":1787392293324,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Boehringer-Ingelheim Vetmedica"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.tvjl.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T19:56:22Z","timestamp":1483646182000},"page":"51-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin"],"prefix":"10.1016","volume":"220","author":[{"given":"E.","family":"Royaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Van Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.G.","family":"Broeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Van Soens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Deforce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-8348","authenticated-orcid":false,"given":"S.F.M.","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2017.01.002_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2460\/javma.240.6.705","article-title":"A systematic review of the safety of potassium bromide in dogs","volume":"15","author":"Baird-Heinz","year":"2012","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1939-1676.2002.tb02367.x","article-title":"A cross-sectional study of epilepsy in Danish Labrador Retrievers: Prevalence and selected risk factors","volume":"18","author":"Berendt","year":"2002","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1939-1676.2007.tb03017.x","article-title":"Premature death, risk factors, and life patterns in dogs with epilepsy","volume":"21","author":"Berendt","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12917-015-0464-z","article-title":"International Veterinary Epilepsy Task Force consensus proposal: Medical treatment of canine epilepsy in Europe","volume":"11","author":"Bhatti","year":"2015","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0030","series-title":"Small Animal Clinical Pharmacology and Experimental Therapeutics","first-page":"950","article-title":"Anticonvulsant and other neurological therapies in small animals","author":"Boothe","year":"2012"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0035","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2460\/javma.240.9.1073","article-title":"Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs","volume":"240","author":"Boothe","year":"2012","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12917-014-0257-9","article-title":"Treatment in canine epilepsy \u2013 a systematic review","volume":"10","author":"Charalambous","year":"2014","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0050","series-title":"Phenobarbital, Canine and Feline Epilepsy: Diagnosis and Management","first-page":"374","author":"De Risio","year":"2014"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0055","series-title":"Canine and Feline Epilepsy: Diagnosis and Management","first-page":"396","article-title":"Bromide","author":"De Risio","year":"2014"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12917-015-0462-1","article-title":"International Veterinary Epilepsy Task Force consensus proposal: Diagnostic approach to epilepsy in dogs","volume":"11","author":"De Risio","year":"2015","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0070","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2460\/javma.1984.184.09.1117","article-title":"Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy","volume":"184","author":"Farnbach","year":"1984","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1748-5827.1997.tb02977.x","article-title":"Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 Labrador retrievers: A long-term study","volume":"38","author":"Heynold","year":"1997","journal-title":"The Journal of Small Animal Practice"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1939-1676.2009.0438.x","article-title":"Epilepsy in border collies: Clinical manifestation, outcome and mode of inheritance","volume":"24","author":"H\u00fclsmeyer","year":"2010","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2885.2002.00440.x","article-title":"Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles","volume":"25","author":"March","year":"2002","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/vr.122.15.346","article-title":"Effectiveness of a therapeutic drug-monitoring service as an aid to the control of canine seizures","volume":"122","author":"Morton","year":"1988","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0120","series-title":"BSAVA Manual of Canine and Feline Neurology","first-page":"105","article-title":"Seizures","author":"Podell","year":"2004"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1939-1676.1993.tb01025.x","article-title":"Bromide therapy in refractory canine idiopathic epilepsy","volume":"7","author":"Podell","year":"1993","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jvim.13841","article-title":"2015 ACVIM small animal consensus statement on seizure management in dogs","volume":"30","author":"Podell","year":"2016","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12917-015-0548-9","article-title":"Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up","volume":"11","author":"Rundfeldt","year":"2015","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2885.1985.tb00934.x","article-title":"Therapeutic efficacy of phenobarbital and primidone in canine epilepsy \u2013 a comparison","volume":"8","author":"Schwartz-Porsche","year":"1985","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tvjl.2007.03.003","article-title":"Findings on low-field cranial MR images in epileptic dogs that lack interictal neurological deficits","volume":"176","author":"Smith","year":"2008","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jvp.12151","article-title":"Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs","volume":"38","author":"Tipold","year":"2015","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2017.01.002_bib0195","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2460\/javma.1998.213.10.1449","article-title":"Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992\u20131996)","volume":"213","author":"Trepanier","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023317300072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023317300072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:30:43Z","timestamp":1749864643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023317300072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"alternative-id":["S1090023317300072"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2017.01.002","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}